Menlo Therapeutics Inc. (MNLO) financial statements (2021 and earlier)

Company profile

Business Address 200 CARDINAL WAY, 2ND FLOOR
REDWOOD CITY, CA 94063
State of Incorp. DE
Fiscal Year End December 31
SIC 2834 - Pharmaceutical Preparations (benchmarking)
More info Complete financial analysis Financial benchmarking

Balance sheet (Statement of financial position) ($ in millions)

12/31/2019
12/31/2018
12/31/2017
ASSETS
Current Assets
Cash, cash equivalents, and short-term investments7713660
Cash and cash equivalents315010
Short-term investments468749
Receivables  1
Other undisclosed current assets134
Total current assets:7814064
Noncurrent Assets
Operating lease, right-of-use asset1
Property, plant and equipment000
Long-term investments and receivables  3
Long-term investments  3
Other undisclosed noncurrent assets00 
Total noncurrent assets:103
TOTAL ASSETS:7914067
LIABILITIES AND EQUITY
Liabilities
Current Liabilities
Accounts payable and accrued liabilities10106
Accounts payable432
Accrued liabilities664
Deferred revenue and credits2
Other undisclosed current liabilities1  
Total current liabilities:11108
Noncurrent Liabilities
Liabilities, other than long-term debt 07
Deferred revenue and credits7
Other liabilities 00
Total noncurrent liabilities: 07
Total liabilities:111015
Stockholders' equity
Stockholders' equity attributable to parent69130(57)
Common stock000
Additional paid in capital2532412
Accumulated other comprehensive income (loss)0(0)(0)
Accumulated deficit(184)(111)(59)
Other undisclosed stockholders' equity  109
Total stockholders' equity:6913052
TOTAL LIABILITIES AND EQUITY:7914067

Income statement (P&L) ($ in millions)

12/31/2019
12/31/2018
12/31/2017
Revenue, net5
Gross profit: 115
Operating expenses(76)(65)(34)
Operating loss:(76)(55)(30)
Nonoperating income
(Other Nonoperating income)
33 
Net loss:(74)(51)(30)
Other undisclosed net income attributable to parent  1
Net loss available to common stockholders, diluted:(74)(51)(29)

Comprehensive Income ($ in millions)

12/31/2019
12/31/2018
12/31/2017
Net loss:(74)(51)(30)
Comprehensive loss:(74)(51)(30)
Other undisclosed comprehensive income (loss), net of tax, attributable to parent0(0)0
Comprehensive loss, net of tax, attributable to parent:(74)(51)(29)

Statements sources

The financial statements are based on the company's filings with the The U.S. Securities and Exchange Commission (SEC) through the Electronic Data Gathering, Analysis, and Retrieval system (EDGAR). The information is derived from the 10-K and 10-Q reports submitted to the SEC in XBRL (eXtensible Business Reporting Language) format and presented according to the US GAAP Taxonomy. Please review the original filings for a more detailed information.

Login to ReadyRatios

 

Have you forgotten your password?

Are you a new user?

Login As
You can log in if you are registered at one of these services: